Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 3 studies | 19% ± 2% |
Insufficient scRNA-seq data for expression of CACFD1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 4011.43 | 226 / 226 | 100% | 64.02 | 406 / 406 |
pancreas | 100% | 1419.84 | 328 / 328 | 100% | 47.17 | 178 / 178 |
brain | 100% | 1213.70 | 2637 / 2642 | 100% | 44.49 | 704 / 705 |
thymus | 100% | 2462.80 | 653 / 653 | 100% | 58.86 | 602 / 605 |
prostate | 100% | 1874.13 | 245 / 245 | 99% | 67.63 | 498 / 502 |
kidney | 100% | 3161.65 | 89 / 89 | 99% | 34.39 | 889 / 901 |
intestine | 100% | 2048.25 | 966 / 966 | 98% | 40.90 | 517 / 527 |
stomach | 100% | 2823.87 | 359 / 359 | 97% | 35.88 | 278 / 286 |
adrenal gland | 100% | 1420.51 | 258 / 258 | 97% | 26.96 | 223 / 230 |
breast | 99% | 1017.25 | 453 / 459 | 98% | 54.44 | 1098 / 1118 |
lung | 100% | 1837.99 | 577 / 578 | 97% | 32.59 | 1121 / 1155 |
bladder | 100% | 1572.76 | 21 / 21 | 97% | 37.71 | 487 / 504 |
uterus | 100% | 1322.26 | 170 / 170 | 96% | 33.16 | 442 / 459 |
ovary | 100% | 1354.48 | 180 / 180 | 95% | 26.00 | 408 / 430 |
esophagus | 100% | 1371.13 | 1445 / 1445 | 85% | 20.00 | 156 / 183 |
skin | 86% | 543.97 | 1562 / 1809 | 92% | 22.86 | 434 / 472 |
eye | 0% | 0 | 0 / 0 | 100% | 51.03 | 80 / 80 |
spleen | 100% | 982.48 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 11.19 | 1 / 1 |
blood vessel | 100% | 1378.74 | 1333 / 1335 | 0% | 0 | 0 / 0 |
muscle | 97% | 672.03 | 782 / 803 | 0% | 0 | 0 / 0 |
adipose | 97% | 659.38 | 1172 / 1204 | 0% | 0 | 0 / 0 |
heart | 97% | 928.73 | 836 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 21.38 | 43 / 45 |
lymph node | 0% | 0 | 0 / 0 | 59% | 9.21 | 17 / 29 |
peripheral blood | 46% | 215.45 | 425 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016192 | Biological process | vesicle-mediated transport |
GO_0008150 | Biological process | biological_process |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005575 | Cellular component | cellular_component |
GO_0055037 | Cellular component | recycling endosome |
GO_0008021 | Cellular component | synaptic vesicle |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005886 | Cellular component | plasma membrane |
GO_0005769 | Cellular component | early endosome |
GO_0005515 | Molecular function | protein binding |
GO_0003674 | Molecular function | molecular_function |
Gene name | CACFD1 |
Protein name | Calcium channel flower homolog (Calcium channel flower domain-containing protein 1) Calcium channel flower domain containing 1 |
Synonyms | PSEC0248 UNQ3071/PRO9903 PSEC0107 C9orf7 |
Description | FUNCTION: Transmembrane protein which mediates synaptic endocytosis and fitness-based cell culling . In response to different stimulus strengths, controls two major modes of synaptic vesicle (SV) retrieval in hippocampal neurons; Clathrin-mediated endocytosis (CME) in response to mild stimulation and activity-dependent bulk endocytosis (ADBE) in response to strong stimulation (By similarity). In cytotoxic T-lymphoocytes (CTLs) facilitates calcium-dependent endocytosis of cytotoxic granules at the immuno synapse (By similarity). Different isoforms work as fitness fingerprints in 'loser' and 'winner' cells and thereby mediate win/lose decisions as part of the cell competition process . .; FUNCTION: [Isoform 1]: Functions with the other flower isoforms to produce tissue-specific fitness fingerprints that identify unfit or fit cells during cell selection processes in order to maintain tissue health . During cell competition, if levels of this isoform in cells is higher than in the surrounding neighboring cells, the cells are recognized as 'winner' cells, and do not undergo elimination via apoptosis . .; FUNCTION: [Isoform 2]: Functions with the other flower isoforms to produce tissue-specific fitness fingerprints that identify unfit or fit cells during cell selection processes in order to maintain tissue health . During cell competition, if levels of this isoform in unfit cells is higher than in the surrounding neighboring cells, the cells are recognized as 'loser' cells, and undergo elimination via apoptosis to be replaced by the surrounding healthy 'winner' cell population . .; FUNCTION: [Isoform 3]: Functions with the other flower isoforms to produce tissue-specific fitness fingerprints that identify unfit or fit cells during cell selection processes in order to maintain tissue health . During cell competition, if levels of this isoform in unfit cells is higher than in the surrounding neighboring cells, the cells are recognized as 'loser' cells, and undergo elimination via apoptosis to be replaced by the surrounding healthy 'winner' cell population . .; FUNCTION: [Isoform 4]: Functions with the other flower isoforms to produce tissue-specific fitness fingerprints that identify unfit or fit cells during cell selection processes in order to maintain tissue health . During cell competition, if levels of this isoform in cells is higher than in the surrounding neighboring cells, the cells are recognized as 'winner' cells, and do not undergo elimination via apoptosis . . |
Accessions | ENST00000316948.9 [Q9UGQ2-1] Q9UGQ2 ENST00000291722.11 [Q9UGQ2-2] ENST00000627083.2 [Q9UGQ2-3] ENST00000630997.2 [Q9UGQ2-4] ENST00000629431.2 [Q9UGQ2-1] ENST00000444798.1 F6TGH8 ENST00000625979.2 [Q9UGQ2-2] ENST00000542192.5 [Q9UGQ2-3] ENST00000540581.5 [Q9UGQ2-4] |